Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)

被引:32
|
作者
Allerston, Charles K.
Shimizu, Makiko
Fujieda, Masaki
Shephard, Elizabeth A.
Yamazaki, Hiroshi
Phillips, Ian R.
机构
[1] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England
[2] UCL, Dept Biochem & Mol Biol, London, England
[3] Showa Pharmaceut Univ, Lab Drug Metab & Pharmacokinet, Tokyo, Japan
[4] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan
基金
英国惠康基金;
关键词
balancing selection; evolution; flavin-containing monooxygenase; FMO; haplotype; human; linkage disequilibrium; mutation; nucleotide diversity; single-nucleotide polymorphism;
D O I
10.1097/FPC.0b013e328256b198
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Flavin-containing monooxygenase 3 (FMO3) is involved in the metabolism of foreign chemicals, including therapeutic drugs, and thus mediates interactions between humans and their chemical environment. Loss-of-function mutations in the gene cause the inherited disorder trimethylaminuria, or fish-odour syndrome. The objective was to gain insights into the evolutionary history of FMO3. Methods Genetic diversity within FMO3 was characterized by sequencing 6.3 kb of genomic DNA, encompassing the entire coding sequence, some intronic and 3'-untransiated region, and 3.4 kb of 5'-flanking sequence, in 23 potential trimethylaminuric Japanese, and the same 3.4 kb 5'-flanking region in 45 unaffected Japanese. Mutational relationships among haplotypes were inferred from a reduced-median network. The time depth of the variation and ages of individual mutations were estimated by maximum-likelihood coalescent analysis. Test statistics were used to investigate whether the variation is compatible with neutral evolution. Results Sixteen single-nucleotide polymorphisms (SNPs) were identified, which segregated as seven distinct haplotypes. Estimated ages of the mutations indicate that almost all predated migration out of Africa. Analysis of the heterozygosity of FMO3 SNPs indicates that genetic differentiation among continental populations is low (F(ST)=0.050). Test statistics, based on allele-frequency spectrum, number and diversity of haplotypes, linkage disequilibrium and interspecific sequence comparisons, showed a significant departure from neutral expectations, because of an excess of intermediate-frequency SNPs and haplotypes, a ragged pairwise mismatch distribution and an excess of replacement polymorphisms. Conclusion The results provide evidence that FMO3 has been the subject of balancing selection. Finally, we identify mutations that are potential targets for selection.
引用
收藏
页码:827 / 839
页数:13
相关论文
共 50 条
  • [1] Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria
    Zhang, J
    Tran, Q
    Lattard, V
    Cashman, JR
    PHARMACOGENETICS, 2003, 13 (08): : 495 - 500
  • [2] A novel mutation in the flavin-containing monooxygenase 3 gene (FMO3) of a Norwegian family causes trimethylaminuria
    Allerston, C. K.
    Vetti, H. H.
    Houge, G.
    Phillips, I. R.
    Shephard, E. A.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 198 - 202
  • [3] Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria
    Motika, Meike S.
    Zhang, Jun
    Zheng, Xueying
    Riedler, Kiersten
    Cashman, John R.
    MOLECULAR GENETICS AND METABOLISM, 2009, 97 (02) : 128 - 135
  • [4] Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population
    Shimizu, Makiko
    Kobayashi, Yuko
    Hayashi, Shoko
    Aoki, Yuka
    Yamazaki, Hiroshi
    MOLECULAR GENETICS AND METABOLISM, 2012, 107 (03) : 330 - 334
  • [5] Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease
    Phillips, Ian R.
    Shephard, Elizabeth A.
    XENOBIOTICA, 2020, 50 (01) : 19 - 33
  • [6] Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population
    Yamazaki, Hiroshi
    Fujita, Haruka
    Gunji, Takaaki
    Zhang, Jun
    Kamataki, Tetsuya
    Cashman, John R.
    Shimizu, Makiko
    MOLECULAR GENETICS AND METABOLISM, 2007, 90 (01) : 58 - 63
  • [7] Phenotyping of flavin-containing monooxygenase using caffeine metabolism and genotyping of FMO3 gene in a Korean population
    Park, CS
    Chung, WG
    Kang, JH
    Roh, HK
    Lee, KH
    Cha, YN
    PHARMACOGENETICS, 1999, 9 (02): : 155 - 164
  • [8] Trimethylamine biosensor with flavin-containing monooxygenase type 3 (FMO3) for fish-freshness analysis
    Mitsubayashi, K
    Kubotera, Y
    Yano, K
    Hashimoto, Y
    Kon, T
    Nakakura, S
    Nishi, Y
    Endo, H
    SENSORS AND ACTUATORS B-CHEMICAL, 2004, 103 (1-2): : 463 - 467
  • [9] Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndrome
    Dolphin, CT
    Janmohamed, A
    Smith, RL
    Shephard, EA
    Phillips, IR
    PHARMACOGENETICS, 2000, 10 (09): : 799 - 807
  • [10] Genetic polymorphisms of flavin-containing monooxygenase (FMO)
    Krueger, SK
    Williams, DE
    Yueh, MF
    Martin, SR
    Hines, RN
    Raucy, JL
    Dolphin, CT
    Shephard, EA
    Phillips, IR
    DRUG METABOLISM REVIEWS, 2002, 34 (03) : 523 - 532